Skip to content

A clinical trial to study the effect of intranasal dexmedetomidine on spinal anaesthesia shivering .

Effect of intranasal dexmedetomidine on post spinal anaesthesia shivering during Cesarean delivery:A Randomized Clinical Trial - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/08/071988
Enrollment
60
Registered
2024-08-06
Start date
Unknown
Completion date
Unknown
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: 1- Obstetrics

Interventions

Intervention1: Intranasal Dexmedetomidine: Preoperative intranasal dexmedetomidine 1 mcg/kg diluted to 1 ml NS for post spinal anaesthesia shivering Control Intervention1: Normal Saline: Preoperati

Sponsors

Sri Venkateswara Institute of Medical Sciences
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Age between 20-45 years. 2.ASA-PS II and III. 3.Weight between 45 to 75 kgs. 4.Normothermic 36.5 to 37.5 degree C 5.Stable hemodynamics SBP greater than 100mmhg.

Exclusion criteria

Exclusion criteria: 1.Declining to participate or receive spinal anaesthesia. 2.Absolute contraindications to spinal anaesthesia. 3.Height less than 100 cms. 4.Morbid obesity with BMI greater than 40KG/M2 . 5.Known allergy to dexmedetomidine or bupivacaine. 6.Use of epidural catheter. 7.Presence of significant cardiac, liver or renal problems.

Design outcomes

Primary

MeasureTime frame
TO DETERMINE THE OCCURENCE OF CLINICALLY SIGNIFICANT POST SPINAL ANAESTHESIA SHIVERINGTimepoint: Immediately after spinal anaesthesia, 5,10,15,20,30,45,60 mins and at the end of the surgery.Post operative every 30 mins for 120 mins

Secondary

MeasureTime frame
GRADE OF SHIVERING GRADE OF SEDATION OCCURENCE OF NAUSEA,VOMITING, BRADYCARDIA,HYPOTENSION.Timepoint: Immediately after spinal anaesthesia,post spinal at 1,3,5,10,20,30,40,50 min,1,2,4,6 hrs

Countries

India

Contacts

Public ContactDr Aloka Samantaray

SRI VENKATESWARA INSTITUTE OF MEDICAL SCIENCES

aloksvims@gmail.com9493547653

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026